Dr. Anja Schweizer
Fähigkeiten und Kenntnisse
Werdegang
Berufserfahrung von Anja Schweizer
- Current 8 years and 2 months, since Apr 2018
Senior Director Clinical Development– Atherosclerosis
Novartis Pharma AG
Global Clinical lead of the CANTOS OLE study for Canakinumab (anti-human IL-1β antibody) with >5’700 patients in 39 countries worldwide Medical/Scientific Expert for regulatory submission-related activities, including responses to Health Authority questions and preparation for a FDA Advisory Committee Meeting
- 3 years and 6 months, Oct 2014 - Mar 2018
Global Medical Affairs Director - Heart Failure
Novartis Pharma AG
Global Lead & Medical/Scientific Expert for REPORT-HF, the largest to date global, prospective, non-interventional heart failure disease registry with >18’800 patients in 44 countries worldwide
- 2 years and 9 months, Jan 2012 - Sep 2014
Global Medical Affairs Director – Diabetes
Novartis Pharma AG
Led multiple Medical Affairs projects, including Galvus phase IV studies, medical review & approval of promotional/media material and medical communication 6 month assignment a.i. Galvus Global Brand Medical Director (2013)
- 2 years and 9 months, Apr 2009 - Dec 2011
Director, Clinical Development – Diabetes
Novartis Pharma AG
Preparation of Galvus worldwide registration documents, including for EMA, PMDA Japan, sFDA China, SwissMedic
- 11 months, May 2008 - Mar 2009
Senior Medical/Scientific Expert, Clinical Development – Diabetes
Novartis Pharma AG
Led combined phase II/III (adaptive / seamless) development program
- 1 year and 1 month, Apr 2007 - Apr 2008
Scientific Officer - Cardiovascular & Metabolism
Novartis Pharma AG
Responsible for the peer review and approval of company protocols and clinical development plans in Cardiovascular & Metabolism
- 2 years, Apr 2005 - Mar 2007
Senior Clinical Research Manager – Diabetes
Novartis Pharma AG
Key role in the global clinical development & registration of the diabetes drug Galvus Global Head of the Group of Clinical Research Managers/Scientists in charge of the Phase III Galvus registration program Core member of the Galvus Global Clinical Leadership Team & the International Project Team Major contribution to the preparation of registration documents & experience in HA interactions Main author of key Phase II and III publications
- 1 year and 7 months, Sep 2003 - Mar 2005
Clinical Research Manager – Diabetes
Novartis Pharma AG
- 1 year and 11 months, Oct 2001 - Aug 2003
Senior Clinical Research Scientist – Starlix, Galvus
Novartis Pharma AG
- 1 year and 8 months, Feb 2000 - Sep 2001
Clinical Research Scientist – Starlix, Galvus
Novartis Pharma AG
- 1 year, Feb 1999 - Jan 2000
Research Scientist - Vascular Tone, CNS & Protein Trafficking
Friedrich Miescher Institute for Biomedical Research
- 7 months, Jul 1998 - Jan 1999
Lab Head – Cardiovascular Preclinical Research
F. Hoffman La Roche AG
- 2 years and 1 month, Jul 1996 - Jul 1998
Post Doc – Cardiovascular Preclinical Research
F. Hoffman La Roche AG
- 3 years and 4 months, Sep 1992 - Dec 1995
Post Doc – Hematology/Oncology Division
Washington University School of Medicine
Ausbildung von Anja Schweizer
- 2001 - 2003
Pharmaceutical Medicine
EUCOR Universities Basel, Freiburg, Strasbourg
- 1988 - 1991
Biochemistry / Cell Biology
Biocenter University of Basel
- 1984 - 1988
Biology II (Biochemistry/Cell Biology/Molecular Genetics/Biophysical Chemistry)
Universität Basel
Sprachen
German
C2 (Verhandlungssicher / Muttersprachlich)
English
C1 (Fließend)
French
A1-A2 (Grundkenntnisse)
XING – Das Jobs-Netzwerk
Über eine Million Jobs
Entdecke mit XING genau den Job, der wirklich zu Dir passt.
Persönliche Job-Angebote
Lass Dich finden von Arbeitgebern und über 20.000 Recruiter·innen.
21 Mio. Mitglieder
Knüpf neue Kontakte und erhalte Impulse für ein besseres Job-Leben.
Kostenlos profitieren
Schon als Basis-Mitglied kannst Du Deine Job-Suche deutlich optimieren.